API Import of Amcenestrant obtained from Indian Customs Trade Statistics

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

API Suppliers

API Suppliers

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

0

Listed Suppliers

Other Suppliers

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: Sar439859, 2114339-57-8, Sar-439859, Amcenestrant [inn], Amcenestrant [usan], Tbf1nhy02o
Molecular Formula
C31H30Cl2FNO3
Molecular Weight
554.5  g/mol
InChI Key
KISZAGQTIXIVAR-VWLOTQADSA-N
FDA UNII
TBF1NHY02O

Amcenestrant
Amcenestrant is an orally available, nonsteroidal selective estrogen receptor degrader/downregulator (SERD), with potential antineoplastic activity. Upon oral administration, amcenestrant specifically targets and binds to the estrogen receptor (ER) and induces a conformational change that promotes ER degradation. This prevents ER-mediated signaling and inhibits both the growth and survival of ER-expressing cancer cells.
1 2D Structure

Amcenestrant

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
6-(2,4-dichlorophenyl)-5-[4-[(3S)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylic acid
2.1.2 InChI
InChI=1S/C31H30Cl2FNO3/c32-23-8-12-27(29(33)18-23)28-4-1-3-21-17-22(31(36)37)7-11-26(21)30(28)20-5-9-24(10-6-20)38-25-13-16-35(19-25)15-2-14-34/h5-12,17-18,25H,1-4,13-16,19H2,(H,36,37)/t25-/m0/s1
2.1.3 InChI Key
KISZAGQTIXIVAR-VWLOTQADSA-N
2.1.4 Canonical SMILES
C1CC2=C(C=CC(=C2)C(=O)O)C(=C(C1)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)OC5CCN(C5)CCCF
2.1.5 Isomeric SMILES
C1CC2=C(C=CC(=C2)C(=O)O)C(=C(C1)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)O[C@H]5CCN(C5)CCCF
2.2 Other Identifiers
2.2.1 UNII
TBF1NHY02O
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Sar439859

2. 2114339-57-8

3. Sar-439859

4. Amcenestrant [inn]

5. Amcenestrant [usan]

6. Tbf1nhy02o

7. (s)-8-(2,4-dichlorophenyl)-9-(4-((1-(3-fluoropropyl)pyrrolidin-3-yl)oxy)phenyl)-6,7-dihydro-5h-benzo[7]annulene-3-carboxylic Acid

8. 6-(2,4-dichlorophenyl)-5-[4-[(3s)-1-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7h-benzo[7]annulene-2-carboxylic Acid

9. 8-(2,4-dichlorophenyl)-9-[4-[[(3s)-1-(3-fluoropropyl)-3-pyrrolidinyl]oxy]phenyl]-6,7-dihydro-5h-benzocycloheptene-3-carboxylic Acid

10. 5h-benzocycloheptene-3-carboxylic Acid, 8-(2,4-dichlorophenyl)-9-(4-(((3s)-1-(3-fluoropropyl)-3-pyrrolidinyl)oxy)phenyl)-6,7-dihydro-

11. 6-(2,4-dichlorophenyl)-5-[4-[(3~{s})-1-(3-fluoranylpropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7~{h}-benzo[7]annulene-2-carboxylic Acid

12. 8-(2,4-dichlorophenyl)-9-(4-(((3s)-1-(3-fluoropropyl)-3-pyrrolidinyl)oxy)phenyl)-6,7-dihydro-5h-benzocycloheptene-3-carboxylic Acid

13. Unii-tbf1nhy02o

14. Amcenestrant [jan]

15. Amcenestrant [who-dd]

16. Chembl4475463

17. Schembl19131426

18. Us9714221, Example 51

19. Bdbm263716

20. Ex-a4678

21. Nsc827675

22. S9609

23. Who 11312

24. Nsc-827675

25. Hy-133017

26. Cs-0109407

27. Q66885452

28. 8-(2,4-dichlorophenyl)-9-(4-(((3s)-1-(3-fluoropropyl)pyrrolidin-3-yl)oxy)phenyl)-6,7-dihydro-5h-benzo(7)annulene-3-carboxylic Acid

29. L5b

2.4 Create Date
2017-10-07
3 Chemical and Physical Properties
Molecular Weight 554.5 g/mol
Molecular Formula C31H30Cl2FNO3
XLogP35.3
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count8
Exact Mass553.1586774 g/mol
Monoisotopic Mass553.1586774 g/mol
Topological Polar Surface Area49.8 Ų
Heavy Atom Count38
Formal Charge0
Complexity832
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty